Press Releases Trex Wind-down, Inc.

Equities

TMBRQ

US8870802084

Delayed OTC Markets Other stock markets 12:12:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.0002 ^USD	0.00%		+100.00%	-83.33%

Apr. 04	First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.	CI
Mar. 20	Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals	Jan. 24	AQ
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market	Nov. 29	AQ
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American	Nov. 28	AQ
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance	23-09-18	AQ
Timber Pharmaceuticals : Announces NYSE Acceptance of Plan to Regain Listing Compliance - Form 8-K	23-09-18	PU
TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR	23-08-29	BU
Timber Pharmaceuticals : Why Is Skillz (SKLZ) Stock Up 20% Today	23-08-23	PU
LEO Pharma Signs Agreement to Acquire Timber Pharmaceutical	23-08-22	AQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTG, ESTE, PR, TMBR	23-08-21	PR
TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders	23-08-21	BU
Timber Pharmaceuticals to be Acquired by LEO Pharma	23-08-21	AQ
Timber Pharmaceuticals Discloses Communication From NYSE American	23-07-03	AQ
Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis	23-06-20	AQ
Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001	23-06-05	AQ
TIMBER PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-15	AQ
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results	23-05-15	AQ
Timber Pharmaceuticals : GAAP EPS of -$9.19, revenue of $0.08M misses by $0.72M	23-04-03	PU
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results	23-03-31	AQ
TIMBER PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-31	AQ
Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology	23-03-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Trex Wind-down, Inc.

Equities

TMBRQ

US8870802084

Press Releases

Filters